RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Pyoderma Gangrenosum: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Penile pyoderma gangrenosum.
López Riquelme I et al., Actas dermo-sifiliograficas (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42887848/
- 2.
Pyoderma gangrenosum and haematochezia in a patient with previous cocaine abuse
Myrianthi Hadjicharalambous et al., European Journal of Case Reports in Internal Medicine (14 October 2026)
https://doi.org/10.12890/2026_007405
- 3.
Pyoderma gangrenosum: Clinico-diagnostic approach and skin ulcer care
E. V. Lebedeva et al., Meditsinskiy sovet = Medical Council (10 October 2026)
https://doi.org/10.21518/ms2026-395
- 4.
Self-Inflicted Disease, Reported as Pyoderma Gangrenosum
Andrea Dai et al. (7 October 2026)
https://doi.org/10.13140/rg.2.2.12396.12165
- 5.
Pyoderma Gangrenosum Arising in a Field of Superficial Radiation Therapy: A Novel Complication With Implications for Nonmelanoma Skin Cancer Management.
Nadir Umer et al., Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42821776/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
NCT06624670 · Recruiting · Phase 3 · LEO Pharma
Ages 18 and over
https://clinicaltrials.gov/study/NCT06624670
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Pyoderma Gangrenosum
Pyoderma gangrenosum is a rare inflammatory skin condition that causes painful, rapidly growing ulcers, most often on the legs. It is not an infection and is not contagious. It is sometimes linked to other conditions such as inflammatory bowel disease or arthritis. Treatment usually involves medicines that calm the immune system, along with careful wound care.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Pyoderma Gangrenosum?
Pyoderma gangrenosum is a rare inflammatory skin condition that causes painful, rapidly growing ulcers, most often on the legs. It is not an infection and is not contagious. It is sometimes linked to other conditions such as inflammatory bowel disease or arthritis. Treatment usually involves medicines that calm the immune system, along with careful wound care.
How many clinical trials are available for Pyoderma Gangrenosum?
RareWays currently indexes 30 clinical trials for Pyoderma Gangrenosum, of which 3 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Pyoderma Gangrenosum come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Pyoderma Gangrenosum.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.